DEAR DR. GOTT: What is the latest information about the early-Alzheimer’s pill? How early or at what age or at what signs should it be taken?
DEAR READER: My guess is that you are referring to Rember, what we all hope will be a breakthrough drug. It is a new formulation of methylene blue, an old product. More than two years ago, British scientists reported a new drug that was designed to slow Alzheimer’s disease. The trial involved 321 people with mild to moderate Alzheimer’s in the United Kingdom and Singapore. The patients were divided into four groups, three of which took different doses of Rember, and the fourth was provided a placebo. [Read more...]